Alteration of TGFB1, GDF9, and BMPR2 Gene Expression in Preantral Follicles of an Estradiol Valerate-induced Polycystic Ovary Mouse Model Can Lead to Anovulation, Polycystic Morphology, Obesity, and Absence of Hyperandrogenism

Overview

Journal Clin Exp Reprod Med

Date 2021 Aug 9

PMID 34370943

Citations 4

Authors

Reza Asghari

Vahid Shokri-Asl

Hanieh Rezaei

Mahmood Tavallaie

Mostafa Khafaei

Amir Abdolmaleki

Abbas Majdi Seghinsara

Affiliations

Soon will be listed here.

Abstract

Objective: In humans, polycystic ovary syndrome (PCOS) is an androgen-dependent ovarian disorder. Aberrant gene expression in folliculogenesis can arrest the transition of preantral to antral follicles, leading to PCOS. We explored the possible role of altered gene expression in preantral follicles of estradiol valerate (EV) induced polycystic ovaries (PCO) in a mouse model.

Methods: Twenty female balb/c mice (8 weeks, 20.0±1.5 g) were grouped into control and PCO groups. PCO was induced by intramuscular EV injection. After 8 weeks, the animals were killed by cervical dislocation. Blood serum (for hormonal assessments using the enzyme-linked immunosorbent assay technique) was aspirated, and ovaries (the right ovary for histological examinations and the left for quantitative real-time polymerase) were dissected.

Results: Compared to the control group, the PCO group showed significantly lower values for the mean body weight, number of preantral and antral follicles, serum levels of estradiol, luteinizing hormone, testosterone, and follicle-stimulating hormone, and gene expression of TGFB1, GDF9 and BMPR2 (p<0.05). Serum progesterone levels were significantly higher in the PCO animals than in the control group (p<0.05). No significant between-group differences (p>0.05) were found in BMP6 or BMP15 expression.

Conclusion: In animals with EV-induced PCO, the preantral follicles did not develop into antral follicles. In this mouse model, the gene expression of TGFB1, GDF9, and BMPR2 was lower in preantral follicles, which is probably related to the pathologic conditions of PCO. Hypoandrogenism was also detected in this EV-induced murine PCO model.

Citing Articles

Transcription factor YY1 adversely governs ovarian granulosa cell growth in PCOS by transcription activation-mediated CDKN1C upregulation.

Dong S, Liu Y, Yang Z Funct Integr Genomics. 2024; 24(5):171.

PMID: 39317806 DOI: 10.1007/s10142-024-01448-2.

Casein kinase 1α mediates estradiol secretion via CYP19A1 expression in mouse ovarian granulosa cells.

Luo X, Zhang D, Zheng J, Liu H, Sun L, Guo H BMC Biol. 2024; 22(1):176.

PMID: 39183304 PMC: 11346181. DOI: 10.1186/s12915-024-01957-3.

Cocktails of NSAIDs and 17α Ethinylestradiol at Environmentally Relevant Doses in Drinking Water Alter Puberty Onset in Mice Intergenerationally.

Philibert P, Dejardin S, Girard M, Durix Q, Gonzalez A, Mialhe X Int J Mol Sci. 2023; 24(6).

PMID: 36982971 PMC: 10099742. DOI: 10.3390/ijms24065890.

Single intratesticular injection of blood-serum-derived exosomes can potentially alleviate testopathy following testicular torsion.

Keivan M, Torghabeh F, Davoodi S, Moradi Maryamneghari S, Dadfar R Animal Model Exp Med. 2022; 5(4):362-368.

PMID: 35593125 PMC: 9434569. DOI: 10.1002/ame2.12232.

References

Venegas B, De Leon Gordillo L, Rosas G, Espinoza J, Moran C, Dominguez R . In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation. Reprod Biol Endocrinol. 2019; 17(1):95. PMC: 6862835. DOI: 10.1186/s12958-019-0539-y. View

Persani L, Rossetti R, Di Pasquale E, Cacciatore C, Fabre S . The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders. Hum Reprod Update. 2014; 20(6):869-83. DOI: 10.1093/humupd/dmu036. View

Ghadami M, Makita Y, Yoshida K, Nishimura G, Fukushima Y, Wakui K . Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3. Am J Hum Genet. 2000; 66(1):143-7. PMC: 1288319. DOI: 10.1086/302728. View

Norman R, Noakes M, Wu R, Davies M, Moran L, Wang J . Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update. 2004; 10(3):267-80. DOI: 10.1093/humupd/dmh018. View

Raja-Khan N, Urbanek M, Rodgers R, Legro R . The role of TGF-β in polycystic ovary syndrome. Reprod Sci. 2013; 21(1):20-31. PMC: 5933191. DOI: 10.1177/1933719113485294. View

Laird M, Thomson K, Fenwick M, Mora J, Franks S, Hardy K . Androgen Stimulates Growth of Mouse Preantral Follicles In Vitro: Interaction With Follicle-Stimulating Hormone and With Growth Factors of the TGFβ Superfamily. Endocrinology. 2017; 158(4):920-935. PMC: 5460807. DOI: 10.1210/en.2016-1538. View

Grun F, Blumberg B . Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology. 2006; 147(6 Suppl):S50-5. DOI: 10.1210/en.2005-1129. View

Kim E, Jang M, Choi J, Park K, Cho I . An Improved Dehydroepiandrosterone-Induced Rat Model of Polycystic Ovary Syndrome (PCOS): Post-pubertal Improve PCOS's Features. Front Endocrinol (Lausanne). 2018; 9:735. PMC: 6288467. DOI: 10.3389/fendo.2018.00735. View

Moore R, Shimasaki S . Molecular biology and physiological role of the oocyte factor, BMP-15. Mol Cell Endocrinol. 2005; 234(1-2):67-73. DOI: 10.1016/j.mce.2004.10.012. View

10.

Sugiura K, Su Y, Eppig J . Does bone morphogenetic protein 6 (BMP6) affect female fertility in the mouse?. Biol Reprod. 2010; 83(6):997-1004. PMC: 2994326. DOI: 10.1095/biolreprod.110.086777. View

11.

Divyashree S, Janhavi P, Ravindra P, Muthukumar S . Experimental models of polycystic ovary syndrome: An update. Life Sci. 2019; 237:116911. DOI: 10.1016/j.lfs.2019.116911. View

12.

Shi D, Vine D . Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Fertil Steril. 2012; 98(1):185-93. DOI: 10.1016/j.fertnstert.2012.04.006. View

13.

Mahesh V, GREENBLATT R . Isolation of dehydroepiandrosterone and 17alpha-hydroxy-delta5-pregenolone from the polycystic ovaries of the Stein-Leventhal syndrome. J Clin Endocrinol Metab. 1962; 22:441-8. DOI: 10.1210/jcem-22-4-441. View

14.

Makker A, Goel M, Das V, Agarwal A . PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update. Gynecol Endocrinol. 2011; 28(3):175-81. DOI: 10.3109/09513590.2011.583955. View

15.

de Resende L, Vireque A, Santana L, Moreno D, Japur de Sa Rosa E Silva A, Ferriani R . Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation. J Assist Reprod Genet. 2012; 29(10):1057-65. PMC: 3492567. DOI: 10.1007/s10815-012-9825-8. View

16.

Teede H, Deeks A, Moran L . Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010; 8:41. PMC: 2909929. DOI: 10.1186/1741-7015-8-41. View

17.

Miri M, Karimi Jashni H, Alipour F . Effect of exercise intensity on weight changes and sexual hormones (androstenedione and free testosterone) in female rats with estradiol valerate-induced PCOS. J Ovarian Res. 2014; 7:37. PMC: 3997229. DOI: 10.1186/1757-2215-7-37. View

18.

Huang A, Brennan K, Azziz R . Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril. 2009; 93(6):1938-41. PMC: 2859983. DOI: 10.1016/j.fertnstert.2008.12.138. View

19.

Zhang X, Chang H, Zhu H, Liu R, Leung P . BMP6 increases TGF-β1 production by up-regulating furin expression in human granulosa-lutein cells. Cell Signal. 2019; 55:109-118. DOI: 10.1016/j.cellsig.2019.01.002. View

20.

Pinilla L, Trimino E, Garnelo P, Bellido C, Aguilar R, Gaytan F . Changes in pituitary secretion during the early postnatal period and anovulatory syndrome induced by neonatal oestrogen or androgen in rats. J Reprod Fertil. 1993; 97(1):13-20. DOI: 10.1530/jrf.0.0970013. View